Voronoi, Inc. (KOSDAQ:310210)
South Korea · Delayed Price · Currency is KRW 161,100
-2,600 (-1.59%)
Sep 16, 2025, 3:30 PM KST
Voronoi Revenue
Voronoi had revenue of 3.35B KRW in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 3.35B.
Revenue (ttm)
3.35B
Revenue Growth
n/a
P/S Ratio
864.97
Revenue / Employee
23.93M
Employees
140
Market Cap
2,897.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.77B | -5.02B | -33.93% |
| Dec 31, 2021 | 14.78B | 8.60B | 139.22% |
| Dec 31, 2020 | 6.18B | 5.88B | 1,955.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,031.69B |
| Celltrion | 3,748.95B |
| ALTEOGEN | 158.06B |
| Yuhan | 2,165.44B |
| SK Biopharmaceuticals | 620.28B |
| Peptron | 5.18B |
| PharmaResearch | 449.81B |
| ABL Bio | 94.93B |